By Lisa P. Rumin and Anthony S. Ferrara (McDermott Will & Emery)
The December 2023 merger guidelines indicate a shift in perspective from the Federal Trade Commission and the U.S. Department of Justice regarding out-of-market effects, referring to competitive impacts beyond the defined market boundaries.
Firstly, the current antitrust agencies exhibit reluctance towards acknowledging efficiencies originating outside what they define as the relevant market – termed as out-of-market benefits. This stance persists even when a divestiture could maintain these efficiencies while addressing potential concerns within the relevant market.
Conversely, there is a newfound emphasis on evaluating whether market entry or efficiencies within the relevant market could detrimentally affect competition beyond its borders – referred to as out-of-market harms.
Essentially, the current FTC and DOJ consider out-of-market harms but overlook out-of-market benefits in their assessments…
Featured News
Landmark Monopoly Trial Between DOJ and Google Wraps Up
May 2, 2024 by
CPI
Lawmaker Probes FTC and EU’s Role in Amazon’s Failed iRobot Acquisition
May 2, 2024 by
CPI
FTC to Approve Exxon’s $64 Billion Deal with Pioneer Resources
May 1, 2024 by
CPI
UK Competition Watchdog Raises Alarm Over Nvidia’s ARM Takeover
May 1, 2024 by
CPI
Sen. Klobuchar Urges Regulators to Probe Collusion in Healthcare Pricing
May 1, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI